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1. Introduction 
Echinococcosis is a near-cosmopolitan zoonosis caused by tapeworms (cestodes) belonging 
to the family Taeniidae and the genus Echinococcus. This parasitic disease is very common 
but largely neglected. The two major species of medical and public health importance are 
Echinococcus granulosus (Eg) and E. multilocularis (Em), which cause cystic echinococcosis 
(CE) and alveolar echinococcosis (AE), respectively. Globally, CE is responsible for most of 
the burden of echinococcosis (Budke, 2006), although AE is re-emerging with increasing 
frequency in Europe (Deplazes, 2006; Eckert et al., 2000; Romig, 2009; Hegglin et al., 2008). 
There are 4 million people infected and more than 100 million at risk of infection including 
many in the EU countries (Craig and Larrieu, 2006; Craig et al., 2007; McManus et al., 2003). 
In the endemic regions, human incidence rates can reach more than 50 per 100 000 
person/year and prevalence as high as 5–10% may occur, as in parts of Peru, Argentina, east 
Africa and central Asia (Altintas, 2003; Craig et al., 2007; Moro et al., 1997). In China, there 
are 60 million people at risk (Ito et al., 2003b) with 550,000 CE patients having visible 
hydatid cysts by ultrasound (Collaboration projects, 2005; Li et al., 2005) and > 100 million 
animals infected(Chi et al., 1989). 
2. Life-cycle and Echinococcosis 
The complex life cycle of Echinococcus involves two hosts (Fig 1); a definitive host and an 
intermediate host. Definitive hosts are carnivores such as dogs, wolves and foxes. Sexual 
maturity of adult E. granulosus occurs in the host small intestine within 4 to 5 weeks of 
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ingesting offal containing viable protoscoleces. Gravid proglottids or released eggs are shed 
in the feces.  
 
Fig. 1. Life cycle of Echinococcus (upper panel) and hepatic echinococcosis scanned by 
computed axial tomography (CT) (lower panels). A, Cystic echinococcosis (CE) due to E. 
granulosus. B, a patient infected with both CE (daughter cysts are marked with small 
arrowheads) and alveolar echinococcosis (AE, large arrowhead). C, AE due to E. 
multilocularis infection (arrowhead).  
Intermediate hosts are herbivores such as sheep, horses, cattle, pigs, goats, camels, moose, 
kangaroos and wallabies. Humans are accidental hosts and generally play no part in 
transmission. Intermediate hosts and humans become infected by ingesting eggs of the 
parasites, which are released in the faeces of the definitive hosts. The eggs hatch in the 
gastrointestinal tract and become activated larvae (oncospheres) which penetrate the 
intestinal wall and enter the bloodstream, eventually locating in internal organs, where they 
develop into hydatid cysts. Hydatid cysts of E. granulosus develop in internal organs of 
intermediate hosts and humans as fluid-filled bladders (Figure 1A). The cysts can be located 
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in almost all organs, with about 70% of cysts in the liver, 20% in the lungs, with the 
remainder involving other organs such as the kidney, spleen, brain, heart and bone. 
A typical cyst of E. granulosus consists of two parasite-derived layers; an inner nucleated 
germinal layer and an outer acellular laminated layer surrounded by a host-produced 
fibrous capsule. Brood capsules and protoscoleces bud off from the germinal membrane.  
The alveolar cyst  or metacestode of E. multilocularis develops differently to that of E. 
granulosus, being a complex tumor-like multivesicular, infiltrating structure consisting of 
numerous small vesicles embedded in stroma of connective tissue (Fig 1B and C). The larval 
mass usually contains a semisolid matrix, rather than fluid, with granulomatous infiltration 
of mononuclear cells around the parasitic vesicles, a hallmark of AE, culminating in 
irreversible fibrosis. Adult worm infections of E. multilocularis occur mainly in red and arctic 
foxes, although dogs and cats (rarely) can also act as definitive hosts. Small mammals 
(usually microtine and arvicolid rodents) act as intermediate hosts (Fig 1). 
The chronic disease of CE is characterized in humans and domestic and wild ungulates by 
long term growth of metacestode (hydatid) cysts in the internal organs of intermediate 
hosts. Clinical manifestations are mild in the early stages of infection, and normally remain 
asymptomatic for a long period, but the host does produce detectable humoral and cellular 
responses against the infection, while the parasite has evolved highly effective evasive 
strategies to aid in long term survival. Immunity to E. granulosus infection is typical of a 
chronic infection and the host responses are pivotal for developing laboratory-based 
diagnostic procedures. 
The proliferative larval stages of E. granulosus and E. multilocularis can ‘leak” out of a 
ruptured cyst (E. granulosus) or metastisize (E. multilocularis) to another organ or tissue 
naturally producing a condition known as secondary CE or AE, respectively. This also 
allows the parasites to be passaged serially from one intermediate host to another by 
intraperitoneal implantation of the larvae, simplifying the technical difficulties and danger 
associated with cyclic passage through both definitive and intermediate hosts.   
CE and AE are both serious diseases, the latter especially so, with a poor prognosis if careful 
clinical management is not carried out. In the later stages of echinococcosis, as the disease 
progresses, the parasite may physically damage tissues and organs which can become 
dysfunctional and can be fatal, especially in AE, when the parasite destroys the liver 
parenchyma, bile ducts and blood vessels resulting in biliary obstruction and portal 
hypertension. In most late-stage cases a necrotic cavity, containing  viscous fluid, may form 
in the liver.  
3. Host immune responses against infection 
Immune responses play an important role in the host-parasite interplay in echinococcosis. 
The mammalian host produces immune responses to reject and/or limit the growth of the 
parasite, whereas, the parasite produces molecules to avoid these immune attacks. One 
phenomenon of the infection is self-cure, which is commonly observed in sheep (Zhang and 
Zhao, 1992; Cabrera et al., 2003) and also occurs in humans in hyper-endemic areas (Wang et 
al., 2006; Moro et al., 2005; Macpherson et al., 2004). Indeed, more than 70% of cysts 
surgically removed from a large cohort of Chinese patients were shown to be inactive and 
www.intechopen.com
 
Serological Diagnosis of Certain Human, Animal and Plant Diseases 
 
116 
calcified (Peng, XY, personal communication), indicating that the number of human self-
cure cases can be substantial. However, details of this important, likely immunologically-
based process, remain limited. In addition, some intermediate hosts such as cattle produce a 
high percentage - >90% - of cysts that are infertile in that  they do not contain protoscoleces, 
the developmental form of the parasite infective to the definitive host (Fig. 1), with host 
species-specific differences in immunity probably the key factor (Zhang et al., 2003a). 
Similarly in AE, some patients with calcified lesions (Gottstein and Felleisen, 1995) are likely 
due to self-cure.  
This self-cure phenomenon raises the possibility that protective immune responses against 
parasite growth and dissemination may exist. However, little is known about the 
determinants which may restrain metacestode survival and proliferation, or eliminate 
Echincococcus infection. 
Although the data are limited, there is, nevertheless, clear evidence, from experiments with 
animals challenged with E. granulosus/E. multilocularis eggs or oncospheres that infected 
hosts produce significant immune responses, including antibody and T cell responses 
generated by lymphocytes. Understanding the mechanisms whereby these immune 
responses are produced, particularly the role of protective antibodies against the 
oncosphere, has been of fundamental importance in developing highly effective 
recombinant vaccines against both E. granulosus and E. multilocularis.  
3.1 Antibody responses  
The earliest immunoglobin (Ig) G response to E. granulosus hydatid cyst fluid and 
oncospheral antigens appears after 2 and 11 weeks, respectively, in mice and sheep 
challenged with eggs or oncospheres of E. granulosus (Zhang et al., 2003b; Yong et al., 
1984). Anti-oncospheral antibodies play a major role in parasite killing and are central to 
the protective immune response against E. granulosus (Read et al., 2009). In the chronic 
phase of CE, elevated antibody levels, particularly IgG, IgM and IgE, occur in humans 
(Khabiri et al., 2006; Daeki et al., 2000; Pinon et al., 1987; Craig, 1986; Dessaint et al., 1975) 
(Fig. 2), with IgG1 and IgG4 being predominant (Daeki et al., 2000; Sterla et al., 1999; Wen 
and Craig, 1994). In murine models of AE infection, IgG and IgM were significantly 
increased after 9 weeks post-infection (p.i) with eggs (Matsumoto et al., 2010). Antibody 
responses to protoscolex antigens are relatively weak and delayed in the early stage of E. 
multilocularis infection in mice, but are increased later (Bauder et al., 1999; Matsumoto et 
al., 1998); IgG1 and IgG3 levels increase significantly at 8 weeks p.i, and remain elevated 
thereafter (Li et al., 2003a).  
Antibody production is a pre-requisite for the development of serodiagnostic tests, but 30-
40% of patients are antibody-negative for CE. In many of these patients, however, varying 
levels of circulating antigens (CAg) and circulating immune complexes (CIC) are 
measurable (Craig, 1993). This phenomenon suggests that B cell activity and proliferation  
may be regulated and inhibited by E. granulosus antigens. It is not known whether these 
antigens directly target B cells or via T cell regulatory mechanisms. One study showed that 
after infection, CD4-knockout mice and C57Bl/6 mice had similar titres of specific 
antibodies, indicating that antibody production may be T cell-independent in early infection 
(Baz et al., 2008). 
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Fig. 2. Immune responses during the development of a hydatid cyst of E. granulosus in the 
intermediate host. In the early stage of infection, the oncosphere is transported to a host 
organ such as the liver or lung where it develops into a hydatid cyst. The immature cyst has 
to overcome host, mainly cell-mediated, immune responses, especially the infiltration of 
macrophages and eosinophils and low level polarized Th1 responses. About 8-10 weeks 
post-infection in mice, cyst growth is maintained and complex echinococcal antigens are 
released from the cyst. These antigens stimulate complex immune responses. These include 
polarized Th2 responses, balanced with Th1 responses. At this time, the parasite produces 
significant quantities of antigens that help to modulate the immune response, which may 
benefit both host and parasite; IgG, especially IgG1 and IgG4, IgE and IgM levels are 
elevated. When the cyst is dead, dying or surgically removed, the Th2 responses drop 
rapidly, whereas the Th1 responses drop slowly then becoming polarized. IgG can be 
maintained in the human host for many years after the cyst is surgically removed. Once an 
infected patient has relapsed, the Th2 responses recover very quickly, while other responses 
are elevated slowly. M, macrophage; E, eosinophil. 
In addition, antibody responses may indicate the infectious status (Li et al., 2010; Delunardo 
et al., 2010; Reiter-Owona et al., 2009; Ben Nouir et al., 2008; Ortona et al., 2005).  A survey of 
246 CE patients showed that E. granulosus antigen B (AgB) specific antibody was elevated in 
a significantly greater proportion (87.3%) of subjects with active or transitional stage cysts 
(CE1, CE2, or CE3), compared with 54.8% of other patients with inactive or early stage cysts 
(CL, CE4 or CE5). Furthermore, AgB-specific antibody was detected in 95.6% of CE2 cases, 
which was statistically higher than that (73.7%) in CE1 patients (Li et al., 2010).  Results from 
173 AE patients showed that serum antibody levels against Em18 were significantly 
correlated with the disease phase (Li et al., 2010).  
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A survey of  861 children in China showed that serological tests can also be as an indicator 
of Echinococcus transmission; this study predicated the transmission of echinococcosis due to 
changes in the ecology and socio-geography in and around endemic communities (Yang et 
al., 2008). 
3.2 T cell responses   
During the early stages of an echinococcal infection, there is a marked activation of cell-
mediated immunity including cellular inflammatory responses and pathological changes 
(Zhang et al., 2003a; Zhang et al., 2008b). Cellular infiltration of eosinophils, neutrophils, 
macrophages, and fibrocytes occurs in humans (Magambo et al., 1995; Peng et al., 2006) and 
sheep (Petrova, 1968) infections. However, this generally does not result in a severe 
inflammatory response and aged cysts tend to become surrounded by a fibrous layer that 
separates the laminated cystic layer from host tissue. 
Early Th1 polarized cytokine production, which can kill the metacestode at the initial stages 
of development (Vuitton, 2003), then shifts to a predominant Th2 cytokine response in the 
later, chronic stage, and is characteristic of E. granulosus and E. multilocularis infection (Fig. 
2). Very little is known of cytokine production in the early phases of a primary (oral 
challenge with eggs) E. granulosus infection, although both Th1 and Th2 cytokine levels are 
low in the early stages of a primary E. multilocularis infection, but are raised subsequently 
(Bauder et al., 1999). As well, it is thought the Th2 cytokines are responsible for inhibition of 
parasite killing because of the anti-inflammatory action of interleukin-10 (IL-10) (Bauder et 
al., 1999; Vuitton, 2003). The Th2-type cytokines profile in abortive AE patients was opposite 
to those in progressive patients, with IL -10 and IL-5 associated with the progression of 
disease (Godot et al., 2000). However, secondary E. multilocularis infection in a mouse model 
showed that Th1 cytokines play a role in resistance of parasite growth (Emery et al., 1997). 
Patients with chronic CE generate both Th1 and Th2 responses (Baz et al., 2006). Given the 
recent advances in understanding the immunoregulatory capabilities of helminthic 
infections, it has been suggested that Th2 responses play a crucial role in chronic 
helminthiasis (Allen and Maizels, 2011). However, a remarkable feature of chronic CE 
infection is the coexistence of interferon-gamma (IFN-γ), IL-4 and IL-10 at high levels in 
human echinococcosis (Mezioug and Touil-Boukoffa, 2009).  It is unclear why hydatid 
infection can induce high levels of both Th1 and Th2 cytokines (Rigano et al., 1995a) since 
they usually down-regulate each other (Pearce and MacDonald, 2002). Antigen and the 
amount of antigens released may play key roles. For instance, E. granulosus AgB skewed 
Th1/Th2 cytokine ratios towards a preferentially immunopathology-associated Th2 
polarization, predominantly in patients with progressive disease (Rigano et al., 2001).  
Liver pathology in AE is characterized by the presence of a huge granulomatous infiltrate of 
mononuclear cells involving mainly macrophages, myofibroblasts and T lymphocytes 
(Harraga et al., 2003; Vuitton et al., 1989). In the progressive forms of the disease, the T cell 
infiltrate within the periparasitic granuloma is mainly composed of CD8 T lymphocytes 
(Bresson-Hadni et al., 1990). 
A hallmark of chronic Echinococcus infection is the presence of high levels of IL–10 (Zhang et 
al., 2008a; Vuitton, 2003), a cytokine typically associated with immunoregulation of effector 
responses (Moore et al., 2001). The role of IL-10 in chronic infection largely remains unclear, 
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although one report showed that IL-10 may impair the Th1 protective response and allow 
the parasite to survive in hydatid patients (Moore et al., 2001). By inducing the host to 
produce high levels of IL-10, E. multilocularis appears able to modulate the immune response 
so that the T cells infiltrating the periparasitic granuloma cannot participate in the effector 
phase of the cellular immune response (Zhang et al., 2008a; Vuitton, 2003). The interaction of 
the Echinococcus organisms with their mammalian hosts may provide a highly suitable 
model to address some of the fundamental questions remaining such as the molecular basis 
underpinning the different effects of IL-10 on different cell types; the mechanisms of 
regulation of IL-10 production; the inhibitory role of IL-10 on monocyte/macrophage and 
CD4 T cell function; its involvement in stimulating the development of B cells and CD8 T 
cells; and its role in the differentiation and function of T regulatory cells. 
In addition, the production of subgroups of chemokines (CC and CXC) associated with 
inflammation (MIP-1 alpha(macrophage inflammatory protein 1 alpha)/CCL3, MIP-1 
beta/CCL4, RANTES (regulated upon activation, normally T-cell expressed and 
secreted)/CCL5 and GRO-alpha (growth-regulated oncogene-alpha)/CXCL1) in peripheral 
blood mononuclear cells stimulated with Em antigens in vitro was constitutively larger in 
AE patients than in controls(Kocherscheidt et al., 2008). However, in patients, Em 
metacestodes suppressed cellular chemokine production, and this may constitute an 
immune escape mechanism which reduces inflammatory host responses, prevents tissue 
destruction and organ damage, but may also facilitate parasite persistence (Kocherscheidt et 
al., 2008). 
It is not known whether the significant cellular infiltration of macrophages and neutrophils 
occurring as the parasite develops results from the innate immune mechanisms of the host 
and the release of chemotactic substances by the parasite or whether it is dependent on 
Th0/Thl cytokines. A large number of CD4(+) T lymphocytes are present in AE patients 
with aborted or dead lesions, whereas patients with active parasites display a significant 
increase in activation of predominantly CD8(+) T cells (Manfras et al., 2002) indicating that 
CD4(+) T cells may play a role in the killing mechanism. This is supported by experiments 
undertaken with genetically modified mice (Dai et al., 2001). Conversely, E. multilocularis is 
able to survive and persist in its host indefinitely for long periods of time. In fact, the murine 
immune response fails to clear infection even when presented with the lowest possible 
infection dose by injection with a single parasite vesicle (Gottstein et al., 2002).  
3.3 Correlation of cytokines with antibody production 
It is noteworthy that the increased production of IL-4 and IL-10 in hydatid patients 
(Bayraktar et al., 2005) corresponds with high levels of IgE and IgG4 (Rigano et al., 1995b), 
suggesting regulation by IL-4 of IgE and IgG4 responses (Rigano et al., 2001; Rigano et al., 
1995b; King and Nutman, 1993). Patients with a primary infection have higher levels of IL-2, 
IFN-γ and IL-5. The effect of IL-5 on human B cells is controversial (Clutterbuck et al., 1989), 
but a significant correlation between IL-5 production and IgE/IgG4 expression has been 
found in hydatid patients (Rigano et al., 1996), indicating that IL-5 is associated with the 
regulation of specific IgE/IgG4 expression. When CE cysts grow, IgG1 and IgG4 levels are 
elevated, whereas the concentrations of specific IgG1 and IgG4 decline in cases 
characterized by cyst infiltration or calcification. This indicates that the IgG4 antibody 
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response is also associated with cystic development, growth and disease progression, 
whereas the IgG1, IgG2 and IgG3 responses occur predominantly when cysts become 
infiltrated or are destroyed by the host (Daeki et al., 2000). 
3.4 T cell responses and treatment 
The polarized T cell responses in echinococcosis have been shown to be modulated by the 
developmental status of the hydatid cyst, as shown by experiments with T-cell lines 
generated from patients with active, transitional and inactive hydatid cysts and stimulated 
with sheep hydatid fluid antigens. It is likely due to the antigens containing distinct 
epitopes for each T-cell subset as a single recombinant protein can stimulate both types of 
response (Zhang et al., 2003a). T-cell  lines from a patient with an inactive cyst had a Th1 
profile, while T-cell lines derived from patients with active and transitional hydatid cysts 
had mixed Th1/Th2 and Th0 clones (Rigano et al., 2004), indicating that Th1 lymphocytes 
contribute significantly to the inactive stage of hydatid disease, with Th2 lymphocytes being 
more important in the active and transitional stages. When CE patients were drug-treated 
with albendazole/mebendazole, a Th1 cytokine profile, rather than a Th2 profile, typically 
dominated, indicating that Th1 responses have a role in the process of cyst degeneration 
(Rigano et al., 1995b). An increased Th1-type cytokine IFN-γ response has been suggested as 
a marker for monitoring AE patient treatment (Dvoroznakova et al., 2004), whereas as 
measurement of serum IL-4 may be a useful marker for the follow up of patients with CE 
(Rigano et al., 1999b). 
One aspect that is likely to be important in the control of such immunological mechanisms is 
the influence of CD4+ T-helper lymphocytes as they may impact on treatment of 
echinococcosis (Vuitton, 2004). As indicated earlier, self-cure is a common feature of  CE 
infection in sheep (Zhang and Zhao, 1992; Cabrera et al., 2003), and it most likely also 
happens in human populations in hyper-endemic areas as patients with calcified cysts are 
often reported (Moro et al., 2005; Macpherson et al., 2004). Cytokines are likely to play a key 
role in the process of self-cure and this is an important area that needs further research.  
Both in vitro and in vivo studies have shown that high levels of the Th1 cytokine IFN-γ were 
found in patients who responded to chemotherapy,  whereas high levels of Th2 cytokines l 
(IL-4 and IL-10) occurred in patients who did not (Rigano et al., 1999b; Rigano et al., 1999a; 
Rigano et al., 1995b; Rigano et al., 1995a). 
3.5 Dendritc cells 
Some recent studies have focused on dendritic cells (DC) and their regulation on other 
immune responses in CE. E. granulosus antigens influence maturation and differentiation of 
DC stimulated with lipopolysaccharide (LPS) (Kanan and Chain, 2006). This includes down-
modulation of CD1a expression and up-regulation of CD86 expression, a lower percentage 
of CD83(+) cells being present, and down-regulation of interleukin-12p70 (IL-12p70) and 
TNF alpha (Rigano et al., 2007). In addition, hydatid cyst fluid (HCF) modulates the 
transition of human monocytes to DC, impairs secretion of IL-12, IL-6 or PGE2 in response 
to LPS stimulation, and modulates the phenotype of cells generated during culture, 
resulting in increased CD14 expression (Kanan and Chain, 2006). AgB has been shown to 
induce IL-1 receptor-associated kinase phosphorylation and activate nuclear factor-kappa B, 
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suggesting that Toll-like receptors could participate in E. granulosus-stimulated DC 
maturation (Rigano et al., 2007). 
E. multilocularis infection in mice induced DC expressing high levels TGF and very low 
levels of IL-10 and IL-12, and the expression of the surface markers CD80, CD86 and CD40 
was down-regulated (Mejri et al., 2011a; Mejri et al., 2011b). However, the higher level of IL-4 
than IFN-γ/IL-2 mRNA-expression in AE-CD4+ pT cells indicated DC play a role in the 
generation of a regulatory immune response (Mejri et al., 2011a). 
Different E. multilocularis antigens have been shown to stimulate different expression 
profiles of DC. Em14-3-3-antigen induced CD80, CD86 and MHC class II surface expression, 
but Em2(G11) failed to do so. Similarly, LPS and Em14-3-3 yielded elevated IL-12, TNF-I+/- 
and IL-10 expression levels, while Em2(G11) did not. The proliferation of bone marrow DC 
isolated from AE-diseased mice was abrogated (Margos et al., 2011), indicating the E. 
multilocularis infection inhibited T cell responses. 
3.6 Regulatory T cells 
Chronic Echinococcus infection results in the suppression of host immune responses, 
allowing long-term parasite survival and restricting pathology. Current theories suggest 
that regulatory T cells (Treg) play an important role in this regulation. However, the 
mechanism of Treg induction during Echinococcus infection is still unknown, although 
several studies have focused on this area.  
A subpopulation of regulatory CD4+ CD25+ T cells isolated from E. multilocularis-infected 
mice reduced ConA-driven proliferation of CD4+ pT cells. The high expression levels of 
Foxp3 mRNA by CD4+ and CD8+ peritoneal T cells suggested that subpopulations of 
regulatory CD4+ Foxp3+ and CD8+ Foxp3+ T cells were involved in modulating the 
immune responses in the chronic stage of AE, which are Th2 polarized responses (Mejri et 
al., 2011b). 
A primary infection with oncospheres of E. granulosus in mice (Zhang et al., 2001) generated 
a low level antibody response during the first 8 weeks (Zhang et al., 2003b), possibly 
indicating host immunosuppression. After 9 weeks of the primary infection, antibodies 
against hydatid cyst fluid and oncosphere antigens were significantly increased, suggesting 
that antibody production during the course of the infection may be regulated, perhaps 
through periodic release of antigen from cysts and/or general down regulation of B-cells 
through T-helper cell activity. 
AgB is the most evaluated echinococcal antigen for its role in modulation of immune 
responses. AgB significantly inhibits polymorphonuclear cell recruitment (Rigano et al., 
2001; Shepherd et al., 1991), modulates dendritic cell differentiation and polarizes 
immature DC maturation towards a Th2 cell response (Rigano et al., 2007).  After 
establishment in the host, the hydatid cyst produces a large amount of AgB (Zhang et al., 
2003b), which can alter  the Th1/Th2 ratio from a predominant Th1 response in the early 
stage of infection to a Th2 response (Rigano et al., 2001), indicating that AgB is a 
modulator of the T cell response benefiting parasite survival. A number of studies have 
shown that AgB is encoded by a gene family and the antigen exhibits a high degree of 
www.intechopen.com
 
Serological Diagnosis of Certain Human, Animal and Plant Diseases 
 
122 
genetic polymorphism (Haag et al., 2006; Rosenzvit et al., 2006; Kamenetzky et al., 2005), 
suggesting that the Echinococcus organisms have evolved antigenic variation-type  
mechanisms for escaping the host immune response. 
4. Serological diagnosis of human echinococcosis  
Typical asymptomatic features in the early stages of infection and for a long period after 
establishment makes early diagnosis of echinococcosis in humans difficult. Although the 
definitive diagnosis for most human cases of CE is by physical imaging methods, such as X-
ray, ultrasonography, computed axial tomography (CT scanning) and magnetic resonance 
imaging, these procedures are often not readily available in isolated communities and 
usually they provide effective diagnosis mainly of the late development stages of clinical 
infection. Early diagnosis of CE and AE by serology may, therefore, provide opportunities 
for early treatment and more effective chemotherapy. Another practical application of 
serology in human echinococcosis is the follow-up of the treatment. Although hydatid 
disease is an asymptomatic infection, the host does produce detectable humoral and cellular 
responses against the infection. Measurement of these responses is a prerequisite for 
developing effective serodiagnostic tools. 
4.1 Methodology in detecting antibodies 
Almost all serological tests have been developed for immunodiagnosis of human CE cases. 
These include indirect haemagglutination (IHA), latex agglutination (LA), complement 
fixation test (CFT), immunoelectrophoresis (IEP) tests and enzyme-linked immunosorbent 
assay (ELISA) (Rickard et al., 1984; Rickard, 1984). In contrast, the CFT and LA tests are more 
likely to give non-specific or false positive reactions (Rickard, 1984) as is the IHA test when 
serum titres are lower than 1:512 (Varela-Diaz et al., 1975c; Varela-Diaz et al., 1975b; Varela-
Diaz et al., 1975a; Craig and Nelson, 1984).   
There are considerable differences between the various tests both in specificity and 
sensitivity. As the sensitivity of a test increases, so generally does the demand for improved 
antigens in order that sufficient specificity can be achieved to take advantage of the greater 
sensitivity. An optimum test should be specific with high sensitivity.  Insensitive and non-
specific tests including the Cassoni intradermal test, CFT, IHA and LA test have been 
replaced by ELISA, IEP, indirect immunofluorescence antibody test (IFAT),  and 
immunoblotting (IB) in routine laboratory application (Lightowlers and Gottstein, 1995; 
Nasrieh and Abdel-Hafez, 2004)). ELISA achieved sensitivity rates of 88 to 98% using cyst 
fluid preparations (Rickard et al., 1984; Speiser, 1980). 
Recently developed dipstick assays (van Doorn et al., 2007) are considered to be valuable 
methods for CE serodiagnosis. A dipstick assay has been developed that exhibited 100% 
sensitivity and 91.4% specificity with 26 CE sera and 35 other parasite infection sera using 
camel hydatid cyst fluid as antigen (Al-Sherbiny et al., 2004). Since the dipstick assay is 
extremely easy to perform with a visually interpreted result within 15 min, in addition to 
being both sensitive and specific, the test could be an acceptable alternative for use in 
clinical laboratories lacking specialized equipment and the technological expertise needed 
for IB or ELISA.  
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One study (Ortona et al., 2000) highlights the need to standardize techniques and antigenic 
preparations and to improve the performance of immunodiagnosis by characterizing new 
antigens and detecting distinct immunoglobulin classes.  The diagnostic sensitivity and 
specificity of IEP, ELISA and IB, in detecting IgG antibodies in patient sera to native and 
recombinant AgB and a hydatid fluid fraction (HFF) were compared. Sera tested were from 
patients who had CE grouped according to their type of cysts, from patients with other 
parasitic diseases, lung or liver carcinomas or serous cysts, and from healthy controls. HFF-
IB gave the highest sensitivity (80%) followed by ELISA (72%) and IEP (31%). The diagnostic 
sensitivity significantly decreased as cysts matured (from type I-II to type VII, classified by 
ultrasound). Recombinant and native AgB-IB yielded similar sensitivity (74%) but a large 
number of clinically or surgically confirmed CE patients (20%) were negative. In these 
patient sera, IB to assess the usefulness of another recombinant E. granulosus molecule 
(elongation factor-1 beta/delta) in detecting IgE antibodies, yielded 33% of positivity. 
The results of this and other studies suggest that hydatid serology may be improved by 
combining several defined antigens (including synthetic peptides), and the design of new E. 
granulosus-specific peptides that react with otherwise false-negative sera. 
4.2 Immunodiagnosis of cystic echinococcosis in humans 
The immunodiagnosis of echinococcosis has been comprehensively reviewed (Zhang et al., 
2003a).  Over the past decade, diagnosis of CE has improved due to the use of new or more 
optimal methods for purification of Echinococcus antigens from somatic materials, by the 
application of molecular tools for parasite identification and the synthesis of recombinant 
diagnostic antigens and immunogenic peptides. These approaches have not only improved 
the sensitivity and specificity of tests for diagnosis of CE but they have also allowed more 
reliable characterization of the biological status of parasite materials (Zhang and McManus, 
2006; Siles-Lucas and Gottstein, 2001). 
The long history of CE serodiagnosis has mainly involved the identification and 
characterization of specific E. granulosus antigens. The lipoproteins antigen B (AgB) and 
antigen 5 (Ag5), the major components of HCF, have been the two molecules that have 
received wide attention in regards to diagnosis. Both antigens have been well characterized in 
terms of their molecular features and diagnostic potential (Zhang et al., 2003a). Although AgB 
and Ag5 have proved to be diagnostically valuable, there are difficulties related to their lack of 
sensitivity and specificity and problems with the standardization of their use. Cross-reactivity 
with antigens from other parasites, notably other taeniid cestodes, is a major problem. IgE 
cross-reaction with other parasites (Wattal et al., 1988; Force et al., 1992) is common. 
Data in the literature for sensitivity and cross-reactivity of serum anti-Echinococcus IgE differ 
significantly; most studies report high specificity (99–100%) (Marinova et al., 2011; Chamekh 
et al., 1992; Khabiri et al., 2006; Afferni et al., 1984; Sjolander et al., 1989; Zarzosa et al., 1999) 
A recent study using a large panel of sera showed that crude or purified antigens from 
parasite or hydatid cyst fluid generated a reasonable high specificity (Feng et al., 2010). By 
using 857 sera from confirmed CE patients and 42 sera from AE patients and 697 sera with 
different infection and medical conditions showed an overall of 93.4% of specificity with  
relative low sensitivity 57.4-68.4%  (Table 1) (Feng et al., 2010). 
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Antigen  Test Number of  subjects tested Sensitivity (%)Specificity 
(%) 
Reference 
  
CE Healthy 
Other 
diseases 
  
 
HBLF LA 119 37 54 86 87.9 (Barbieri et al., 1993) 
HFF IHA 204 90 53 54 100 (Ortona et al., 2000) 
HFF IgE IB 204 90 53 80 96 (Ortona et al., 2000) 
HFF IEP 204 90 53 31 100 (Ortona et al., 2000) 
HCF IgG ELISA 71 45 62 64 80 (Verastegui et al., 1992) 
FBHCF IgG ELISA 119 37 54 83 86.8 (Barbieri et al., 1993) 
sWHF IgG ELISA 111/Li 0 0 89 nd (Babba et al., 1994) 
sWHF IgG ELISA 122/Lu 0 0 78 nd (Babba et al., 1994) 
FBHCF IgG ELISA 90 28 88 84 60 (Barbieri et al., 1998) 
HCF IgG ELISA 87 200 339 94 82.3 (Poretti et al., 1999) 
HCF IgG ELISA 42 15 41 81 95 (Irabuena et al., 2000) 
HFF IgG ELISA 204 90 53 72 97 (Ortona et al., 2000) 
ppHCF IgG ELISA 70 30 73 89 40.8 (Jiang et al., 2001) 
HCF IgG ELISA 129 203 65 78 97 (Virginio et al., 2003) 
HCF IgG ELISA 59 15 55 79 73 (Lorenzo et al., 2005) 
HCF IgG ELISA 26 10 45 96 100 (Al-Sherbiny et al., 2004) 
HCF IgG Dip 26 10 45 100 91 (Al-Sherbiny et al., 2004) 
HCF IgG WB 71 45 62 65 91 (Verastegui et al., 1992) 
HCF AgB IgG Dot-IB 875 5 739 68.4 93.4 (Feng et al., 2010) 
HCF AgB IgG ELISA 857 5 739 57.4 93.4 (Feng et al., 2010) 
HCF AgB IgE WB 324 70 500 86.4 92 (Li et al., 2003b) 
HCF IgG WB 26 10 45 100 91 (Al-Sherbiny et al., 2004) 
HCF IgE 
ImCAP 
155 110 58 73.6 99.1 
(Marinova et al., 2011) 
HCF IgG ELISA 155 110 58 90.3 90.9 (Marinova et al., 2011) 
HCF IgG WB 155 110 58 90.1 94.5 (Marinova et al., 2011) 
Table 1. Features of assays for immunodiagnosis of cystic echinococcosis based on hydatid 
cyst fluid antigens and native proteins from E. granulosus Abbreviations: HFF - hydatid fluid 
fraction, rich in Ag5 and AgB; HBLF - heparin-binding lipoprotein fraction; ppHCF - 
partially purified HCF; FBHCF - fertile bovine hydatid cyst fluid; Li - liver; Lu - lung; sWHF 
- sheep whole hydatid cyst fluid; IHA - indirect haemagglutination assay; LA - Latex 
agglutination assay; IEP - immunoelectrophoresis; ELISA - enzyme - linked immunosorbent 
assay; WB - Western blotting; Dip, dipstick; ImCAP, immunoCAP system. 
4.2.1 E. granulosus antigen B 
E. granulosus antigen B (AgB), a polymeric lipoprotein with a molecular weight of 120 kDa, is a 
highly immunogenic molecule, a characteristic that underpins its value in serodiagnosis (Table 
2). AgB can be measured in patient blood as circulating antigen (Kanwar et al., 1994; Kanwar 
and Kanwar, 1994; Liu et al., 1993). It has a molecular size of circa 8 kDa on sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Lightowlers et al., 1989; Shepherd and 
McManus, 1987) under reduced conditions. The function of AgB in the parasite’s biology is not 
completely elucidated, but several studies have shown that the molecule may be involved in 
the modulation of the host immune response; for instance, as a protease inhibitor that inhibits 
neutrophil chemotaxis (Shepherd et al., 1991; Virginio et al., 2007), promoting a non-protective 
Th2 response by interfering with monocyte differentiation, and by modulating DC maturation 
(Kanan and Chain, 2006; Rigano et al., 2007). One study has suggested that AgB could be 
involved in the processes of lipid uptake or detoxification (Chemale et al., 2005).  
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AgB Test Number of  subjects tested Sensitivity 
(%) 
Specificity 
(%) 
Reference 
  
CE Healthy
Other 
diseases
   
 
Gel-EF IgG ELISA 204 90 53 74 100 (Ortona et al., 2000) 
pp IgG ELISA
90 28 86 77 85 
(Gonzalez-Sapienza et 
al., 2000) 
pp IgG ELISA 191 50 133 79 98 (Shambesh et al., 1997) 
pp IgG ELISA 81 - 98 89 86 (Wen and Craig, 1994) 
AEC IgG ELISA 31 29 87 77 82 (Rott et al., 2000) 
mAb-AP IgG ELISA 90 28 88 77 86 (Barbieri et al., 1998) 
pp IgG1 
ELISA 
81 - 98 58 92 
(Wen and Craig, 1994) 
pp IgG1 
ELISA 
191 50 133 57 100 
(Shambesh et al., 1997) 
pp IgG2 
ELISA 
81 - 98 53 94 
(Wen and Craig, 1994) 
pp IgG3 
ELISA 
81 - 98 46 95 
(Wen and Craig, 1994) 
pp IgG4 
ELISA 
210 47 79 63 81 
(McVie et al., 1997) 
pp IgG4 
ELISA 
191 50 133 38 99 
(Shambesh et al., 1997) 
pp IgG4 
ELISA 
81 - 98 73 91 
(Wen and Craig, 1994) 
pp IgG4 
ELISA 
210 47 79 63 81 
(McVie et al., 1997) 
AgB IgG ELISA 129 203 65 60 93 (Virginio et al., 2003) 
AgB IgG ELISA 36 36 - 91.7 97.2 (Kalantari et al., 2010) 
AgB IgG ELISA 59 15 55 80 77 (Lorenzo et al., 2005) 
AgB IgG ELISA 40 70 40 92 97 (Sadjjadi et al., 2007) 
pp IgG 
dELISA 
210 47 79 93 65 
(McVie et al., 1997) 
18kDa IgG WB 69 82 63 10 77 (Jiang et al., 2001) 
8 kDa IgG WB 35 200 339 71 97 (Poretti et al., 1999) 
8 kDa IgG WB 52p 200 339 60 97 (Poretti et al., 1999) 
8-34kDa IgG WB 173 29 66(AE) 85 65 (Ito et al., 1999) 
8-34kDa IgG WB 35 200 339 91 94 (Poretti et al., 1999) 
8-34kDa IgG WB 52p 200 339 81 94 (Poretti et al., 1999) 
Gel-EF IgG WB 204 90 53 66 100 (Ortona et al., 2000) 
pp IgG WB 158 29 152 92 69 (Ito et al., 1999) 
pp IgG WB 173 29 115 92 100 (Ito et al., 1999) 
8kDa IgG WB 44 - 43 47.7 51.2 (de la Rue et al., 2010) 
16kDa IgG WB 44 - 43 45.5 67.4 (de la Rue et al., 2010) 
24kDa IgG WB 44 - 43 68.2 62.8 (de la Rue et al., 2010) 
 
Table 2. Features of assays for immunodiagnosis of cystic echinococcosis using native 
antigen B Abbreviations: Gel-EF - eluted fractions from SDS-PAGE; pp - partial purification; 
AEC - anion exchange chromatography; mAb - AP - affinity purification by monoclonal 
antibody; 52p - days post-surgery; AE - alveolar echinococcosis; ELISA - enzyme - linked 
immunosorbent assay; dELISA - dot - ELISA; WB - Western blot. 
AgB is a gene family containing at least 10 genes in 5 subfamilies (Shepherd et al., 1991; 
Fernandez et al., 1996; Chemale et al., 2001; Arend et al., 2004; Mamuti et al., 2007; Zhang et 
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al., 2010), which are differentially expressed in different stages of E. granulosus (Mamuti et 
al., 2007; Zhang et al., 2010). Several AgB cDNAs, such as rAgB8/1 and rAgB8/2, have been 
cloned, expressed as recombinant proteins and used for diagnosis. AgB8/2 provided the 
highest diagnostic sensitivity (84-93.1%) and specificity (98-99.5%) (Rott et al., 2000; Virginio 
et al., 2003). Furthermore, the IgG4 response against AgB appears to be the subclass of choice 
for serological testing (Siracusano et al., 2004).  
The sensitivity and specificity of native E. granulosus cyst fluid antigens and native and 
recombinant AgB are shown in Tables 1-3. These studies used small panel of sera and  
 
 
Antigen Assay method Number of  subjects tested Sensitivity 
(%) 
Specificity 
(%) 
Reference 
  
CE Healthy
Other 
diseases
  
 
rAgB.MBP IgG4 ELISA 210 47 79 65 91 (McVie et al., 1997) 
EG55-GST IgG  ELISA 64 39 105 89 72 (Helbig et al., 1993) 
rAgB8/1 IgG  ELISA 31 29 87 55 80 (Rott et al., 2000) 
rAgB8/2 IgG  ELISA 31 29 87 84 98 (Rott et al., 2000) 
rEgPS-3-GST IgG  ELISA 
119 44 123 74 87 
(Leggatt and McManus, 
1994) 
P176 IgG  ELISA 
90 28 86 80 93 
(Gonzalez-Sapienza et al., 
2000) 
P175 IgG  ELISA 
90 28 86 49 94 
(Gonzalez-Sapienza et al., 
2000) 
P177 IgG  ELISA 
90 28 86 38 92 
(Gonzalez-Sapienza et al., 
2000) 
P65 IgG  ELISA 
90 28 86 44 96 
(Gonzalez-Sapienza et al., 
2000) 
pGu4 IgG  ELISA 
90 28 86 18 98 
(Gonzalez-Sapienza et al., 
2000) 
pGU4 IgG  ELISA 31 29 87 26 - (Rott et al., 2000) 
p65# IgG  ELISA 90 28 88 34-48 80-97 (Barbieri et al., 1998) 
pGU4# IgG  ELISA 90 28 88 12-18 96-100 (Barbieri et al., 1998) 
rAgB.MBP IgG dELISA 210 47 79 74 88 (McVie et al., 1997) 
p65 IgG dELISA 
25 9 8 64 100 
(Leggatt and McManus, 
1994) 
rAgB-GST IgG WB 204 90 53 72 100 (Ortona et al., 2000) 
P176 IgG ELISA 59 15 55 63 82  
rAgB1  59 15 55 68 88 (Lorenzo et al., 2005) 
rAgB1 IgG ELISA 
102 95 68 88.2 80.9 
(Hernandez-Gonzalez et 
al., 2008) 
rAgB2 IgG ELISA 
102 95 68 91.2 93 
(Hernandez-Gonzalez et 
al., 2008) 
        
rAgB-GST IgG IB 120 24 97 79.2 81 (Lv et al., 2009) 
rAgB IgG ELISA 246  173 77.6  (Li et al., 2010) 
 
Table 3. Features of assays for immunodiagnosis of cystic echinococcosis based on using 
recombinant antigen B and antigen B peptides Abbreviations: ELISA - enzyme-linked 
immunosorbent assay; dELISA - dot enzyme - linked immunosorbent assay; ELISAs - 
sandwich ELISA; rEgPS - recombinant protoscolex protein; GST- glutathione S-transferase; 
rAgB - recombinant antigen B; MBP - maltose binding protein; # - coated with different 
buffer; WB-Western blot 
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showed generally both high sensitivity and specificity (Tawfeek et al., 2011; Kalantari et al., 
2010; Abdi et al., 2010; Lv et al., 2009; Sadjjadi et al., 2007; Virginio et al., 2003). Cross-
reactions, mainly with sera from AE patients,  have been reported to be up to 47.7% (de la 
Rue et al., 2010).  
In addition, a number of AgB peptides have been synthesized and used in ELISA for 
diagnostic purposes (Table 3). Peptide antigens have been considered as a way to enhance 
specificity and efforts have been made to define discrete epitopes of AgB and other 
molecules that could be mimicked by synthetic peptides. However, a double-blind, 
randomized multicenter comparison of the diagnostic performance of six major antigens 
(namely, HCF, native AgB, two recombinant AgB subunits, an AgB-derived synthetic 
peptide, and recombinant cytosolic malate dehydrogenase) against the same serum 
collection showed the AgB-derived synthetic peptide provided relatively poor specificity, 
with instead,  one of the recombinant AgB subunits (AgB8/1) being recommended as the 
standard antigen for laboratory analysis (Lorenzo et al., 2005).  
4.2.2 E. granulosus antigen 5 
E. granulosus antigen 5 (Ag5) is a very high molecular weight (approximately 400 kDa) 
lipoprotein complex composed of 57- and 67-kDa components that, under reducing 
conditions, dissociate into 38- and 22- to 24-kDa subunits in SDS-PAGE. Historically, one of 
the most used immunodiagnostic procedures for CE was the demonstration of serum 
antibodies precipitating antigen 5 (arc 5) by immunoelectrophoresis or similar techniques. 
Table 4 shows the performance of antigen 5 for serological diagnosis of human CE. Loss of 
sugar determinants on antigen 5 can reduce the antigenicity of the native protein (Lorenzo 
et al., 2005a). The potential value of specific antibodies of different IgG subclasses and IgE in 
serological diagnosis of CE using an ELISA based on Ag5 has been evaluated (Khabiri et al., 
2006). The presence of IgG1 was demonstrated in all sera from 58 patients with CE. The 
most discriminatory and specific antibodies found in this study were IgG4 and IgE. Only 
one false-positive reaction was observed with IgG4 and no IgE cross-reactivity occurred 
with 40 sera from healthy controls. In 36 sera from patients with parasitic diseases other 
than CE, two false-positive reactions with IgG4 were observed but none occurred with IgE. 
In immunoblotting, it was shown that the IgG1 subclass was responsible for cross-reactivity 
of human antibodies that reacted with the 38kDa subunit of Ag5. IgG4 and IgE antibodies 
could not recognize the 38kDa subunit and under non-reducing conditions reacted with the 
57kDa subunit without any cross-reactivity with other parasites. These results demonstrated 
that IgG4 and IgE are the most important antibodies for serological diagnosis of CE in an 
Ag5-based immunoassay system. Like AgB, Ag5 has been cloned, expressed and tested for 
diagnostic performance but the recombinant protein showed low sensitivity (Table 4). 
4.2.3 Other recombinant proteins and approaches for immunodiagnosis 
Table 4 lists the diagnostic performance of some other recombinant E. granulosus proteins 
cloned recently. Li et al. (2003b) cloned a fragment designated as EpC1 and tested 896 
human serum samples including 324 sera samples from patients with CE, 172 from patients 
with neurocysticercosis, 89 from patients with AE, and 241 from patients with other 
infections or clinical presentations, as well as 70 from confirmed-negative control subjects.  
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Antigen Test Number of objects tested      Reference 
  
CE Heathy
Other 
disease
Sensitivity
θ%χ 
Specificity 
(%) 
 
Arc5 IEP 35 200 289 63 97.2 (Poretti et al., 1999) 
Arc5 IEP 52p* 200 289 58 97.2 (Poretti et al., 1999) 
mAb-AP IgG  ELISA 90 28 88 50 92 (Barbieri et al., 1998) 
mAb-AP IgG  ELISA 39 29 51 54 89 (Gonzalez et al., 2000) 
P89-122# IgG  ELISA 90 28 88 14-21 77-100 (Barbieri et al., 1998) 
rP-29 IgG  ELISA 39 29 51 61 80 (Gonzalez et al., 2000) 
P89-122# IgG  ELISA 39 29 51 44 100 (Gonzalez et al., 2000) 
pAg 5 IgG  ELISA 111(Li) nd nd 89 nd (Babba et al., 1994) 
pAg 5 IgG  ELISA 122(Lu) nd nd 78 nd (Babba et al., 1994) 
nAg5 IgG ELISA 58 40 36 100 70.2 (Khabiri et al., 2006) 
nAg5 IgG1 ELISA 58 40 36 100 70.2 (Khabiri et al., 2006) 
nAg5 IgG4 ELISA 58 40 36 75.8 93 (Khabiri et al., 2006) 
nAg5 IgE ELISA 58 40 36 70 100 (Khabiri et al., 2006) 
rAg5 IgG ELISA 34 18 36 65 89 (Lorenzo et al., 2005b) 
rAg5-38 IgG ELISA 34 18 36 21 97 (Lorenzo et al., 2005b) 
EpC1 IgG WB 324 70 500 88.7 95.6 (Li et al., 2003b) 
rEgcMDH IgG ELISA 59 15 55 45 83 (Lorenzo et al., 2005a) 
HSP20 IgG1/4 WB 95 37 - 64 - (Vacirca et al., 2011) 
Eg19 IgG WB 97 37 58 10 100 (Delunardo et al., 2010) 
E14t IgG  ELISA 
102 95 68 35.3 91.7 
(Hernandez-Gonzalez 
et al., 2008) 
C317 IgG ELISA 
102 95 68 58.8 80.9 
(Hernandez-Gonzalez 
et al., 2008) 
P5 IgG WB 60 - - 97 - (Zhang et al., 2007) 
* post-treatment. Abbreviations: Li - liver; Lu - lung; mAb-AP - affinity purified using monoclonal 
antibody; # - coated with different buffer; pAg5 - purified antigen 5; nd - not determined. 
Table 4. Features of assays for immunodiagnosis of cystic echinococcosis based on using 
native, recombinant and synthetic peptides of antigen 5 and other proteins  
The fusion protein yielded an overall sensitivity of 92.2% and an overall specificity of 95.6%. 
The combined levels of sensitivity and specificity achieved with the rEpC1-GST fusion protein 
for diagnosis of CE were exceptional, taking into account the large panel of serum samples that 
were tested (Li et al., 2003b). The cDNA sequence coding for EpC1 has high amino acid 
sequence identity to a paralogue from Taenia solium, the cause of neurocysticercosis (NCC). To 
determine diagnostic antibody-binding regions on EpC1 recognized specifically by CE sera, 10 
truncated regions (P1-10) of the immunogenic protein were expressed in Escherichia coli and 
subjected to immunoblotting (Zhang et al., 2007). One peptide, designated peptide 5 (P5, fused 
with glutathione-S-transferase (GST)) was positively recognized by sera from mice 
experimentally infected with oncospheres of E. granulosus and sera from surgically confirmed 
CE patients. Sera from NCC patients did not react with any of the peptides used. There are 
four amino acid substitutions in P5 compared with the T. solium sequence and these may form 
part of the epitope inducing CE-specific antibody. Ninety-seven per cent (58 of 60) of sera from 
confirmed CE patients recognized P5-GST. 
By using ELISA, a cytosolic isoform of malate dehydrogenase (EgcMDH), an EF-hand 
calcium-binding protein (EgCaBP2), and a full-length (EgAFFPf) and a truncated form 
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(EgAFFPt, aa 261 370) of actin yielded sensitivities between 58.6% and 89.7%, and three of 
them were considered of complementary value (Virginio et al., 2003).  
A purified alkaline phosphatase (EgAP) extracted from E. granulosus hydatid cyst 
membranes has shown exceptional diagnostic characteristics with 100% specificity without 
any decrease in sensitivity (100%) with significant potential for use in routine diagnosis and 
follow-up of CE patients (Mahmoud and Abou Gamra, 2004). This mirrors the diagnostic 
value previously shown for purified alkaline phosphatase (pAP) from E. multilocularis 
metacestodes (Zhang et al., 2003a). 
Purified recombinant thioredoxin peroxidase from E. granulosus (TPxEg) was used to screen 
sera from heavily infected mice and patients with confirmed hydatid infection (Li et al., 
2004). Only a portion of the sera reacted positively with the EgTPx-GST fusion protein in 
Western blots (69.3% specificity and 39% sensitivity with human sera), suggesting that 
EgTPx may form antibody-antigen complexes or that responses to the EgTPx antigen may 
be immunologically regulated.  
IB revealed anti-HSP20 antibodies in a higher percentage of sera from patients with active 
disease than in sera from patients with inactive disease (Vacirca et al., 2011). A comparison 
of the ImmunoCAP system for testing serum IgE compared with  IgG-ELISA and IgG-
Western blotting revealed the former test had a higher specificity and lower cross-reactivity 
with a sensitivity of 73.6% (Marinova et al., 2011). 
4.3 Immunodiagnosis of alveolar echinococcosis in humans 
A number of advances in the serodiagnosis of AE have occurred in the past 10 years or so. 
These include identification of  novel antigens, such as Em2 and Em18. Em2 was purified 
originally from E. multilocularis metacestode tissue extracts by affinity chromatography 
(Gottstein, 1985). Using AE sera to screen a cDNA library, a clone termed  II/3 was cloned 
and showed very high performance for diagnosis (Vogel et al., 1988). A commerical kit based 
on Em2 and recombinant truncted protein II/3 so called Em2 Plus ELISA has shown high 
performance of AE diagnosis  (Gottstein et al., 1993).  
Em18, an 18-kD antigen from E. multilocularis, is highly specific for detection of AE (Ito et al., 
2003a; Xiao et al., 2003). An ELISA system using the recombinant Em18 antigen (RecEm18) 
could differentially distinguish AE from CE (Ito et al., 2003a) and may be used for 
monitering surgical and/or chemotherapeutic treatment and the follow up of AE patients 
after treatment (Fujimoto et al., 2005). In order to compare the sequential responses of IgG 
subclasses to Em18 in sera from patients with AE, a total of 225 sera from 36 patients at 
different clinical stages according to the WHO-PNM staging system (Pawlowski et al., 2001) 
were tested. The levels of serum IgG and IgG4 against Em18 correlated with the PNM stages 
compared with sera from patients receiving no treatment (Tappe et al., 2010).  
Antibody-screening was performed by (Reiter-Owona et al., 2009) using ELISA, IHA and 
IFAT, and confirmatory testing was done using the commercialized E. multilocularis-specific 
Em2plus-ELISA versus an in-house E. multilocularis-specific Em10-ELISA. The study 
showed that the Em2plus-ELISA reacted with 23.5% CE-positive sera, whereas the Em10-
ELISA did not exhibit any cross-reactivity. In sera from patients with AE, confirmation by 
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both ELISAs was achieved in 57.6% of cases, mostly in patients with an advanced stage of the 
disease and high antibody titers in the screening assays. False-negative reactions with both 
ELISAs occurred in 30.3% cases, mostly in patients who had low antibody levels in the 
screening tests. The Em2plus-ELISA exhibited fewer false-negative reactions than the Em10-
ELISA. WB confirmed the positive results of both assays and was the assay with the highest 
reliability with different stages of CE and AE, followed by the Em2plus-ELISA for AE. High 
antibody titres in the screening assays favour the detection of species-specific antibodies to 
either CE or AE (Reiter-Owona et al., 2009). The features of assays currently available for 
immunodiagnosis of alveolar echinococcosis using different antigens are presented in Table 5.  
 
Antigen TEST Number of  subjects tested
Sensitivity 
(%) 
Specificity 
(%) 
Reference 
  AE Healthy 
Other 
disease 
   
Em2
plus
 IgG ELISA 140 500 400 97.1 90.2 (Gottstein et al., 1993) 
Em2 IgG ELISA 140 500 400 89.3 98.0 (Gottstein et al., 1993) 
Em2
plus
 IgG ELISA 47 - - 81 - (Bart et al., 2007) 
Em2 IgG ELISA 62 - 97 90 65 (Muller et al., 2007) 
rEm10 IgG ELISA 74 39 95 93.2 96.5 (Helbig et al., 1993) 
II/3-10 IgG ELISA 140 500 400 86.4 96.8 (Gottstein et al., 1993) 
CH-10 IgG ELISA 140 500 400 96 39-97 (Gottstein et al., 1993) 
N3C IgG ELISA 140 500 400 96 18-94 (Gottstein et al., 1993) 
pAP IgG ELISA 37 37 95 100 100 (Ravinder et al., 1997) 
Em70 IgG ELISA 39 32 115 100 99 (Korkmaz et al., 2004) 
Em90 IgG ELISA 39 32 115 100 99 (Korkmaz et al., 2004) 
II/3-10 IgG ELISA 62 - 97 79 92 (Muller et al., 2007) 
Em18 IgG ELISA 44 30 99 91 89.1 (Jiang et al., 2001) 
rEm13 IgG ELISA 28 - 72 82.1 100 (Frosch et al., 1993) 
rEm18 IgG IB 66 29 259 97 96.9 (Ito et al., 1999) 
rEm18 IgG IB 33 82 99 91 92.3 (Jiang et al., 2001) 
rEm18 ELISA 19 0 189 100 99 (Xiao et al., 2003) 
EmII Dot-IB 42 - - 91.1 - (Feng et al., 2010) 
Table 5. Features of assays for immunodiagnosis of alveolar echinococcosis using different 
antigens 
Although AE serological diagnosis has made great strides to practical application, a recent 
expert consensus for alveolar echinococcosis diagnosis (Brunetti et al., 2010) stated that the 
most patients with AE are diagnosed at a later stage, which significantly impacts on quality 
of treatment. There is an urgent need for the early diagnosis. The application of new 
techniques is a way to address these issues;  for example, recent microarray analysis 
identified  5 genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37) exhibiting a high level of congruency, 
and these may provide new diagnostic targets to predict disease status and progression 
(Gottstein et al., 2010). 
4.4 Circulating antigen detection  
Antibody detection is likely to indicate exposure to an Echinococcus infection, but it may not 
necessarily point to the presence of an established, viable infection, or the disease. Serum 
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antibodies may persist for a prolonged period, reaching up to 10 years after hydatid cyst 
removal (Li et al., 2004). In addition, the degree of antibody response may be related to the 
location and condition of a mature hydatid cyst. For instance, hydatid cysts in human lung, 
spleen, or kidney tend to be associated with lower serum antibody levels (Zhang and 
McManus, 2006). Furthermore, in Echinococcus-endemic villages, up to 26% or more of the 
general population may have antibodies to HCF antigens, but with only about 2% of the 
villagers having hydatid cysts (Craig et al., 1986; Chai et al., 1989; Gavidia et al., 2008), 
indicating that the antibody levels may not necessarily reflect the true prevalence of CE. 
Antigen detection assays depend principally on the binding of specific polyclonal or 
monoclonal antibodies to parasite antigen present in serum or urine. A number of different 
assays have been developed to detect echinococcal antigens. The standard double antibody 
sandwich ELISA is a common method for measuring the presence and/or concentration of 
circulating parasite antigens. In the test, antibody raised to the targeted protein is coated 
onto a microtiter plate to capture antigen (Fig 3). The same antibody, that is enzyme labeled, 
is commonly used in the tertiary layer of the assay. This type of antigen capture therefore 
relies on the presence of multiple binding sites on the target antigens(s). Efforts to detect 
CAg in CE patients have been reviewed extensively by Craig (Craig et al., 1986). 
CAg in serum is normally in the form of a circulating immune complex (CIC) with some in 
free form. Therefore, the serum needs to be treated with acid buffer or polyethylene glycol 
(PEG) to release and concentrate the circulating antigens. Acidic treatment (0.2 M 
glycine/HCl ) of CE patient serum is quite straightforward to dissociate CIC (Craig et al., 
1986). In a comparison of acid-treatment and PEG precipitation methods, all the sera of 30 
confirmed positive cases of CE had detectable levels of antigen in the acid-treated sera 
(Craig, 1993). However, 23 (77%) and 26 (87%) sera of 30 confirmed cases had free antigen as 
well as CIC of an 8 kDa antigen in the untreated and in the PEG precipitated sera, 
respectively. None of the sera from other patients with parasitic infections or viral hepatitis 
had any detectable levels of 8 kDa antigen in the untreated, acid-treated or PEG-precipitated 
serum samples. These investigations, therefore, suggested that the demonstration of 
circulating antigen employing monospecific antibodies to affinity purified 8 kDa antigen in 
acid-treated sera is more efficient than the detection of free circulating antigen or CIC in 
untreated or in PEG-precipitated sera (Kanwar et al., 1994). 
IgM CICs tend to be positively associated with active hydatid disease (Craig et al., 1986; 
Matossian et al., 1992). Combining measurement of circulating antibody, CICs and CAg 
resulted in an increase from 77% to 90% compared to measurement of serum antibody alone 
(Moosa and Abdel-Hafez, 1994). Antigens in soluble CICs from CE patients have been 
characterized by separating them on SDS-PAGE (Craig et al., 1986) or by ion-exchange fast 
protein liquid chromatography (FPLC)(Bonifacino et al., 1993). Both studies indicated a 
candidate antigen detectable in serum with an approximate relative molecular mass of 60-67 
KDa, and which is also present in cyst fluid. 
Comparison of CAg and IgG antibody using ELISA, together with Western blotting, showed a 
relatively low sensitivity (43%) for detection of specific serum antigen in CE, compared to 75% 
for IgG antibodies (Craig, 1997). However, the specificity of this CAg ELISA was 90% when 
tested against sera from AE patients and 100% against human cysticercosis sera. The limited 
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cross-reactivity may be a way for practical diagnosis of CE in areas where AE and cysticercosis 
are co-endemic. The advantage of CAg detection is its high sensitivity for detecting CE in 54-
57% of patients who are serum antibody negative (Moosa and Abdel-Hafez, 1994; Craig, 1997). 
CAg detection does appear, therefore, to be potentially useful as a secondary test for some 
suspected CE cases where antibody titers are low (Craig et al., 1986; Schantz, 1988). 
A   (1)        (2)       (3)       (4)                       B  (1)      (2)       (3)       (4)
PCR
C   (1)     (2)     (3)     (4)        (5)              D (1)     (2)        (3)          (4)
PCR
First antibody Test antigen       Conjugate      Substrate
Biotinylated antibody     Streptavidin             Biotinylated DNA     Primers
 
Fig. 3. Schematic of ELISA and immuno-PCR for detecting circulating antigen in serum. A. 
Sandwich ELISA. (1) Plate is coated with a capture antibody; (2) Serum sample is added, 
and any antigen present in the serum binds to the capture antibody; (3) Detecting antibody 
conjugate is added and binds to the antigen; (4) Substrate is added, and is converted by the 
enzyme to a detectable form. B. Direct ELISA. Plate is coated with diluted serum containing 
antigen; (2) Detecting antibody is added, and binds to antigen; (3) Enzyme-linked secondary 
antibody is added, and binds to detecting antibody; (4) Substrate is added, and is converted 
by the enzyme to a detectable form. C. Capture immuno-PCR. (1) Plate is coated with 
capture antibody; (2) Serum sample is added; (3) Biotinylated detecting antibody is added 
and binds to antigen; (4) Streptavidin and biotinylated reporter DNA are added, and the 
biotinylated antibody and biotinylated reporter DNA are linked by streptavidin; (5) Primers 
and PCR components are added and PCR or real- time PCR undertaken to quantify antigen. 
D, Non-capture immuno-PCR. Serum sample is coated on the plate and the remainder of the 
steps are as for the capture-imuno-PCR (C). 
A combination of CAg and antibody detection has been shown to increase the sensitivity 
from 85% (antibody only) to 89% (antibody+CAg) in ELISA of 115 surgically confirmed 
hydatid patients, 41 individuals exhibiting other parasitic and unrelated diseases, and 69 
healthy subjects(Barbieri et al., 1994). 
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Urinary hydatid antigen detection by co-agglutination (Co-A) potentially represents a cost-
effective and rapid test for diagnosis of CE in a rural or field setting.  However, the lower  
sensitivity of Co-A for detection of antigen in the urine of a patient whose serum was positive 
for the antigen is possibly due to low levels of antigen in the urine (Ravinder et al., 2000).  
Although there has been no application to date for echinococcal diagnosis, a technique for 
antigen detection, called immuno-polymerase chain reaction (immuno-PCR) (Fig 3 C and 
D), has been developed (Sano et al., 1992). It combines the molecular recognition of 
antibodies with the high DNA amplification capability of PCR. The procedure is similar to 
conventional ELISA but is far more sensitive, and, in principle, could be applied for the 
detection of single antigen molecules. Instead of an enzyme, a DNA molecule is linked to 
the detection antibody and serves as a template for PCR (Fig 3). The DNA molecule is 
amplified and the PCR product is measured by gel electrophoresis. An improvement of this 
method is to amplify the DNA fragment by real-time PCR, thereby eliminating post-PCR 
analysis. Furthermore, real-time PCR is extremely accurate and sensitive, which should 
make it possible to quantitate very low amounts of DNA-coupled detection antibody with 
high accuracy. 
5. Immunodiagnosis of cystic echinococcosis in intermediate host animals  
Research towards developing serological tests for the diagnosis of larval cestode infection in 
animals has been largely unsuccessful. Substantial problems remain, due to the frequent 
existence of multiple infections with different taeniid species, antigenic cross-reactivity 
between these related parasites, and the low level of specific antibody response to infection. 
Problems with poor specificity and sensitivity of traditional serological tests for cysticercosis 
and hydatidosis have prevented the development of any practical test for ante-mortem 
diagnosis of infection. An approach to the diagnosis of Taenia infection by detecting 
circulating parasite antigen (Onyango-Abuje et al., 1996; Lightowlers, 1990; Harrison et al., 
1989) offers some prospect for the development of a practical diagnostic test for 
cysticercosis. 
In comparison with the extensive investigations in humans, relatively little research has 
been directed toward the development of immunodiagnostic techniques for E. granulosus 
infection in domesticated animals such as sheep and cattle. Currently, diagnosis of CE in 
intermediate hosts is based mainly on necropsy procedures. However, up to 37% of animals 
classified as positive at necropsy may be actually false positives caused by unspecific 
granulomas, pseudo-tuberculosis, fatty degeneration, abscesses, caseous lymphadenitis, and 
larval stage of Taenia hydatigena, whereas false negative diagnoses may be due to small intra-
parenchyma cysts (Larrieu et al., 2001; Gatti et al., 2007).  
Accurate serological diagnosis of CE infection in livestock is necessary, but, as indicated 
above, difficult due to serological cross-reactions with several other species of taeniid 
cestodes including Taenia hydatigena and T.ovis (Lightowlers and Gottstein, 1995; Yong et al., 
1984). Furthermore, natural intermediate host animals produce very poor antibody 
responses to infection compared with the relatively high levels of specific antibody seen in 
human infection (Lightowlers and Gottstein, 1995). In sheep, (Lightowlers et al., 1984) 
detected low levels of antibodies to AgB in the sera of some animals, whereas, others have 
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reported reasonable high antibody responses to this molecule (Kanwar and Kanwar, 1994; 
Ibrahem et al., 1996). ELISA techniques using a variety of antigens have been applied to the 
immunodiagnosis of animal CE (Yong et al., 1984). In experimentally infected sheep, 
antibodies to hydatid antigens can be detected as early as 4-6 weeks post-infection (Yong et 
al., 1984).  However, as referred to above, serological cross-reactions between E. granulosus 
and other cestodes limit the specific diagnosis of hydatid infection by ELISA using crude 
parasite antigens (Yong et al., 1984). Affinity purification of crude antigens with antibodies 
from animals immunized with homologous antigen (Craig and Rickard, 1982), or affinity 
depletion of cross-reactive antigens with monoclonal antibody (Craig et al., 1980), only 
partially reduces the cross-reactivity. Polysaccharide antigens from either the secretions 
produced during in vitro cultivation of E. granulosus PSC or from mouse hydatid cyst 
membranes by phenol extraction have been used to test sera from sheep (Ris et al., 1987). 
Although the antibody responses were significantly higher than those of sheep infected with 
T. hydatigena or T. ovis, very high cross-reacting antibody responses in the sera from T. 
hydatigena-infected animals were detected with the antigenic secretions from PSC. Neither 
antigen was sufficiently sensitive or specific for routine serodiagnostic use (Ris et al., 1987). 
To develop an immunological method for the identification of sheep infected with E. 
granulosus, (Kittelberger et al., 2002) used an ELISA with antigen comprising either a purified 8 
kDa hydatid cyst fluid protein (8kDaELISA), a recombinant EG95 oncosphere protein 
(OncELISA) or a crude protoscolex preparation (ProtELISA). Sera used for the assay 
validations were obtained from 249 sheep infected either naturally or experimentally with E. 
granulosus and from 1012 non-infected sheep. The highest diagnostic sensitivity was obtained 
using the ProtELISA at 62.7 and 51.4%, depending on the cut-off. Assay sensitivities were 
lower for the 8kDaELISA and the OncELISA. Diagnostic specificities were high, ranging from 
95.8 to 99.5%, depending on the ELISA type and cut-off level chosen. A few sera from 39 sheep 
infected with T. hydatigena and from 19 sheep infected with T. ovis were recorded as positive. 
Western immunoblot analysis revealed that the dominant antigenic components in the crude 
protoscolex antigen preparation were macromolecules of about 70-150 kDa, most likely 
representing polysaccharides. This study demonstrated that the ProtELISA was the most 
effective immunological method of those assessed for detection of infection with E. granulosus 
in sheep. Because of its limited diagnostic sensitivity of about 50-60%, it could be useful for the 
detection of the presence of infected sheep on a flock basis but cannot be used for reliable 
identification of individual animals infected with E. granulosus. 
In a later study, Simsek and Koroglu (2004) investigated the antigenic characteristics of 
hydatid cyst fluid in sheep by SDS-PAGE to evaluate the sensitivity and specificity of HCF-
ELISA and immunoblotting for diagnosis of sheep hydatidosis. One band with a molecular 
weight of 116 kDa showed 88% sensitivity and 84% specificity in the immunoblot assay. 
Sensitivity (60%) was less but specificity was higher (94%) with the HCF-ELISA (Simsek and 
Koroglu, 2004). Ghorbanpoor et al. (2006) were able to detect specific circulating antigens or 
antibodies in the serum and urine of 13 experimentally infected sheep. 
6. DNA techniques 
In addition to imaging and serological tests, identification of Echinococcus infection via PCR-
based assays and DNA sequencing using tissue biopsy from the patients can be of choice for 
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confirming diagnosis of echinococcosis for these unconfirmed and complicated cases. DNA 
techniques are now available that allow the unambiguosus identification of Echinococcus 
species and E. granulosus strains using metacestode material excised from intermediate and 
human hosts provide a major new approach to the diagnosis of echinococcosis (Yang et al., 
2006; McManus, 2006; McManus and Thompson, 2003; Thompson and McManus, 2001). 
Detection or amplification of E. multilocularis nucleic acids in clinical samples has been used 
in diagnosis of AE infections in patients (Myjak et al., 2003).  
7. The challenges and future directions 
Almost all available immunodiagnostic techniques, including methods for detecting specific 
antibodies and circulating parasite antigens in serum or other body fluids, have been applied 
for diagnosing echinococcosis. However, all the tools developed to date, are generally 
applicable for laboratory research purposes only. None of the available diagnostic tools, kits or 
methods are generally accepted by clinical physicians. Nevertheless, such serological tools are 
potentially important for epidemiological studies, confirmation of infection status and the 
treatment and the monitoring of control programs and efforts should continue so that new 
assays for improved, practical diagnosis of echinococcosis are developed. 
8. Conclusion  
This Chapter provides an update of recent progress in research on the immunology and 
serological diagnosis of echinococcosis caused by E. granulosus and E. multilocularis. Cystic 
echinococcosus (CE) is characterized by long term growth of larval cysts in humans and 
other intermediate hosts, whereas, alveolar echincoccosis is defined by its chronic  
progression in human liver, resulting in high mortality. Although the host-parasite 
interplay, in most cases of AE and CE, appears to be harmonious and clinically 
asymptomatic for a long period after infection, the host does produce detectable humoral 
and cellular responses against the causative parasites. Antibody responses against early E. 
granulosus infection are weak being, usually, undetectable in the early two to three weeks 
following infection. During the establishment stage, the parasite produces significant 
quantities of antigens that modulate the immune response including antibody production, 
which is essential for serodiagnostic measurement. 
It is clear that the improvement of immunodiagnostic methods for echinococcosis has greatly 
contributed to a better understanding of the prevalence and the epidemiology of the infection. 
Immunodiagnostic tests will also provide a valuable tool in measuring the impact of the 
disease on human health and on animal production, data that are still missing in most 
endemic areas. The assays may contribute to the diagnosis of CE and AE and the follow-up of 
treatment. Ultrasound and X-ray imaging methods are generally inaccessible and/or too 
expensive for the rural population at risk. Under these conditions, serology may provide the 
only tool for diagnosis of the infection. Finally, efforts should continue to provide cheap, 
reliable and standardised serodiagnostic methods more widely available for both AE and CE. 
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